Feb 10, 2023
Our expert panel of hugley successful biotech C-leaders jump into best practices to ensure successful early fund raises in the biotech space. Having raised 100's of millions of dollars between them this is a great listen for all of those joining the fundraising roadshow.
Doug Carlson - Cheif Operating and Financial Officer - Avenge Bio
Mike Tusche - Co-CEO - Treadwell Therapeutics
Brian McVeigh - CEO - Code Biotherapeutics
Hosted by Jared Green and Alex Cooke from Phase 3 Search
www.ph3.bio